
News from Atom Bioscience
25 January, 2023
PRESS RELEASE Atom Bioscience Names Stanford University Professor Vibeke Strand, M.D., to its Scientific...
10 November, 2022
PRESS RELEASE Atom Bioscience to Present Final Data from its Positive Phase 2a Clinical Trial in Chronic...
13 September, 2022
PRESS RELEASE Atom Bioscience Announces Abstract for Its Phase 2a Gout Study Accepted for American College...
08 June, 2022
PRESS RELEASE Atom Bioscience to Update Clinical Development of New Drug to Treat Gout at BIO International...
18 May, 2022
PRESS RELEASE On Gout Awareness Day, Let’s Put the Myths to Rest Genetic abnormalities are the real cause...
21 March, 2022
PRESS RELEASE Atom Bioscience Announces Positive Phase 2a Results For Investigational New Drug to Treat...
07 February, 2022
Lead drug targets unmet medical need in chronic gout Provides significant serum uric acid reduction in...
06 January, 2022
Lead drug targets unmet medical need in chronic gout Provides significant efficacy without toxic side...
05 January, 2022
Atom Bioscience Raises $47 Million in Series C Round of Financing to Advance Development of Small Molecule...
27 May, 2020
Atom Bioscience is a biopharmaceutical company focusing on the research and development of metabolic...
Industry News
Arthritis & Rheumatology: Study Compares Gout Treatments with Different Mechanisms of Action –...